Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Mycophenolate mofetil for induction of remission in Wegener's granulomatosis].

× No keyword cloud information.

9 in total

1. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.

Authors: K G C Smith; R B Jones; S M Burns; D R W Jayne
Journal: Arthritis Rheum Date: 2006-09

2. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

Authors: D R Jayne; H Chapel; D Adu; S Misbah; D O'Donoghue; D Scott; C M Lockwood
Journal: QJM Date: 2000-07

3. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.

Authors: R Omdal; K Wildhagen; T Hansen; R Gunnarsson; G Kristoffersen
Journal: Scand J Rheumatol Date: 2005 May-Jun Impact factor: 3.641

4. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

Authors: Kirsten De Groot; Niels Rasmussen; Paul A Bacon; Jan Willem Cohen Tervaert; Conleth Feighery; Gina Gregorini; Wolfgang L Gross; Raashid Luqmani; David R W Jayne
Journal: Arthritis Rheum Date: 2005-08

5. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.

Authors: E Benenson; J W U Fries; B Heilig; M Pollok; A Rubbert
Journal: Clin Rheumatol Date: 2004-11-26 Impact factor: 2.980

6. 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.

Authors: Rainer Birck; Klaus Warnatz; Hanns M Lorenz; Mira Choi; Marion Haubitz; Mathias Grünke; Hans H Peter; Joachim R Kalden; Ursula Göbel; Johannes M Drexler; Osamu Hotta; Rainer Nowack; Fokko J Van Der Woude
Journal: J Am Soc Nephrol Date: 2003-02 Impact factor: 10.121

7. Maintenance of remission with leflunomide in Wegener's granulomatosis.

Authors: C Metzler; C Fink; P Lamprecht; W L Gross; E Reinhold-Keller
Journal: Rheumatology (Oxford) Date: 2004-01-06 Impact factor: 7.580

8. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.

Authors: J C Henes; J Fritz; S Koch; R Klein; M Horger; T Risler; L Kanz; I Koetter
Journal: Clin Rheumatol Date: 2007-05-15 Impact factor: 2.980

9. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.

Authors: Wenche Koldingsnes; Johannes C Nossent
Journal: J Rheumatol Date: 2003-01 Impact factor: 4.666

9 in total

1 in total

1. [Personalized medicine in the choice of conventional immunosuppressants and disease modifying antirheumatic drugs].

Authors: C Fiehn; G Keyßer; H-M Lorenz
Journal: Z Rheumatol Date: 2013-02 Impact factor: 1.372

1 in total